New French agency head to prioritise drug safety, access to innovation
This article was originally published in Scrip
Executive Summary
Dominique Martin, the new director general of the French medicines and health products safety agency, ANSM, says he plans to focus on strengthening post-marketing safety monitoring of medicines, facilitating access to therapeutic innovation, and beefing up France's regulatory influence at the European level.